1.
Heiss, C, Dejam, A, Kleinbongard, P, et al. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA
290, 1030–1031.
2.
Heiss, C, Keen, CL & Kelm, M (2010) Flavanols and cardiovascular disease prevention. Eur Heart J
31, 2583–2592.
3.
Schroeter, H, Heiss, C, Balzer, J, et al. (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA
103, 1024–1029.
4.
Hooper, L, Kay, C, Abdelhamid, A, et al. (2012) Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr
95, 740–751.
5.
Ried, K, Sullivan, TR, Fakler, P, et al. (2012) Effect of cocoa on blood pressure. Cochrane Database Syst Rev
8, CD008893.
6.
Desideri, G, Kwik-Uribe, C, Grassi, D, et al. (2012) Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension
60, 794–801.
7.
Efsa Panel on Dietetic Products N & Allergies (2012) Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J
9, 2474.
8.
D’Agostino, RB Sr., Vasan, RS, Pencina, MJ, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation
117, 743–753.
9.
Adamson, GE, Lazarus, SA, Mitchell, AE, et al. (1999) HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem
47, 4184–4188.
10.
Heiss, C, Jahn, S, Taylor, M, et al. (2010) Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol.
56, 218–224.
11.
Horn, P, Amabile, N, Angeli, FS, et al. (2014) Dietary flavanol intervention lowers the levels of endothelial microparticles in coronary artery disease patients. Br J Nutr, 1–8.
12.
Dupont, WD & Plummer, WD (2007) PS power and sample size program available for free on the Internet. Controlled Clin Trials
18, 274.
13.
Van Bortel, LM, Laurent, S, Boutouyrie, P, et al. (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens
30, 445–448.
14.
Mulligan, AA, Luben, RN, Bhaniani, A, et al. (2014) A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open
4, e004503.
15.
Vogiatzoglou, A, Mulligan, AA, Luben, RN, et al. (2013) Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr, 1–11.
16.
Ottaviani, JI, Momma, TY, Kuhnle, GK, et al. (2012) Structurally related (-)-epicatechin metabolites in humans: Assessment using de novo chemically synthesized authentic standards. Free Radic Biol Med
52, 1403–1412.
17.
Perk, J, De Backer, G, Gohlke, H, et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J
33, 1635–1701.
18.
Yang, Q, Cogswell, ME, Flanders, WD, et al. (2012) Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA
307, 1273–1283.
19.
Ras, RT, Streppel, MT, Draijer, R, et al. (2013) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol
168, 344–351.
20.
Reriani, MK, Dunlay, SM, Gupta, B, et al. (2011) Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil
18, 704–716.
21.
Anderson, TJ, Elstein, E, Haber, H, et al. (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol
35, 60–66.
22.
Ye, Y, Zhao, X, Zhai, G, et al. (2012) Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials. J Cardiovasc Pharmacol Ther
17, 357–365.
23.
Schuler, G, Adams, V & Goto, Y (2013) Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives. Eur Heart J
34, 1790–1799.
24.
Lewington, S, Clarke, R, Qizilbash, N, et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet
360, 1903–1913.
25.
Law, M (2012) A change in paradigm: lowering blood pressure in everyone over a certain age. Ann Med
44,, Suppl. 1, S30–S35.
26.
Fretheim, A, Odgaard-Jensen, J, Brors, O, et al. (2012) Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med
10, 33.
27.
Egan, BM, Laken, MA, Donovan, JL, et al. (2010) Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension
55, 1289–1295.
28.
Turnbull F & Blood Pressure Lowering Treatment Trialists Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet
362, 1527–1535.
29.
Nilsson, PM (2014) Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA). Aging Dis
5, 109–113.
30.
Heiss, C, Sansone, R, Karimi, H, et al. (2015) Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age (Dordr)
37, 9794.
31.
Prospective Studies Collaboration, Lewington, S, Whitlock, G, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet
370, 1829–1839.
32.
Tokede, OA, Gaziano, JM & Djousse, L (2011) Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr
65, 879–886.